Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cance…
Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research
Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, f…
Medicaid reimbursements under ACA improved appointment availability
Increases in Medicaid reimbursement offered to primary care providers under the Affordable Care Act improved appointment availability for Medicaid recipients without increasing wait times, according to recent findings. “Lower payments have been cited as a critical barrier to access for primary care among Medicaid enrollees and are associated with lower provider availability for Medicaid patients,” researcher Daniel Polsky, PhD, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania, and colleagues wrote.
Medicaid reimbursements under ACA improved appointment availability
Increases in Medicaid reimbursement offered to primary care providers under the Affordable Care Act improved appointment availability for Medicaid recipients without increasing wait times, according to recent findings. “Lower payments have been cited as a critical barrier to access for primary care among Medicaid enrollees and are associated with lower provider availability for Medicaid patients,” researcher Daniel Polsky, PhD, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania, and colleagues wrote.
Medicaid reimbursements under ACA improved appointment availability
Increases in Medicaid reimbursement offered to primary care providers under the Affordable Care Act improved appointment availability for Medicaid recipients without increasing wait times, according to recent findings. “Lower payments have been cited as a critical barrier to access for primary care among Medicaid enrollees and are associated with lower provider availability for Medicaid patients,” researcher Daniel Polsky, PhD, executive director of the Leonard Davis Institute of Health Economics at the University of Pennsylvania, and colleagues wrote.
Ocular Therapeutix begins phase 2 clinical trial for sustained release dexamethasone
Ocular Therapeutix enrolled the first patient in a phase 2 clinical trial to evaluate the safety and efficacy of sustained-release dexamethasone to treat inflammatory dry eye disease, according to a press release.A one-time bioresorbable intracanalicul…